Skip to content

SCHEDULE 13D/AAccepted Feb 14, 4:19 PM ET

Abivax S.A. SCHEDULE 13D/A

Sofinnova Crossover I

sec.gov(opens the filing on sec.gov)

Accepted (ET)

4:19 PM

Feb 14, 2025

Filed

Feb 14, 2025

Documents

1

Size

25.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.